Product Information
SERTRALINE HCL 50 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0343 per EA under NDC 68180098603. Its NADAC has been published 35 times since Oct 29, 2025.
Strength
50 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180098603
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077670On Market Since
8/6/2025
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 50 MG TABLET has been published 35 times since Oct 29, 2025, and over the history we have for it it has declined 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0343 per EA |
|---|---|
| All-time high | $0.0388 (Feb 11, 2026) |
| All-time low | $0.0343 (Jun 17, 2026) |
| 52-week high | $0.0388 |
| 52-week low | $0.0343 |
| Median price | $0.0357 |
| Average price | $0.0364 |
| Largest weekly change | -6.6% (Feb 18, 2026) |
| Weeks tracked | 35 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 50 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0343 per EA (NDC 68180098603), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 50 MG TABLET has declined 4.0%. It has been tracked across 35 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 50 MG TABLET?
Since Oct 29, 2025, the NADAC for SERTRALINE HCL 50 MG TABLET has ranged from a low of $0.0343 (Jun 17, 2026) to a high of $0.0388 (Feb 11, 2026), with a median of $0.0357 per EA.
Are there cheaper alternatives to SERTRALINE HCL 50 MG TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE HCL 50 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 50 MG TABLET?
SERTRALINE HCL 50 MG TABLET (NDC 68180098603) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification